SHPMF • OTCMKTS
상해제약그룹
$1.57
1월 15일, 오후 12시 34분 39초 GMT-5 · USD · OTCMKTS · 면책조항
주식미국 상장 증권
전일 종가
$1.55
일일 변동폭
$1.57 - $1.57
52주 변동폭
$0.99 - $1.95
시가총액
702.07억 HKD
평균 거래량
1.57천
주가수익률
-
배당수익률
-
시장 뉴스
재무
손익계산서
수익
순이익
(CNY)2024년 9월전년대비 변동
수익
702.16억8.16%
운영비
43.06억-4.78%
순이익
11.12억-6.29%
순이익률
1.58-13.66%
주당 수익
EBITDA
31.28억15.99%
유효 세율
21.75%
총자산
총부채
(CNY)2024년 9월전년대비 변동
현금 및 단기 투자
423.85억4.22%
총자산
2237.41억4.97%
총부채
1405.84억5.70%
총자기자본
831.58억
발행 주식
37.52억
주가순자산비율
0.08
총자산이익률
3.14%
자본이익률
5.13%
순현금흐름
(CNY)2024년 9월전년대비 변동
순이익
11.12억-6.29%
영업 현금 흐름
22.68억241.50%
투자 현금 흐름
-16.75억-335.23%
자금 조달 현금 흐름
-36.26억-55.26%
순현금흐름
-30.49억-44.04%
잉여 현금 흐름
38.21억177.98%
정보
Shanghai Pharmaceuticals is a Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets. Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of year 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list. Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
설립
1994. 1. 18.
웹사이트
직원 수
49,234
검색
검색어 지우기
검색 닫기
Google 앱
기본 메뉴